EICHORCondition: Overactive Bladder · Sponsor: MedtronicNeuro
The purpose of this prospective, multicenter study is to assess the safety and efficacy of tibial neuromodulation using the Medtronic Tibial Neuromodulation (TNM) system.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Urology Centers of Alabama | Homewood, Alabama, United States | — |
| Georgia Urology | Cartersville, Georgia, United States | — |
| Northwestern Medicine | Chicago, Illinois, United States | — |
| Providea Health Partners | Evergreen Park, Illinois, United States | — |
| University of Iowa Hospitals and Clinics | Iowa City, Iowa, United States | — |
| Louisiana State University Health Sciences Center | New Orleans, Louisiana, United States | — |
| Chesapeake Urology Associates | Towson, Maryland, United States | — |
| Henry Ford Health System | Detroit, Michigan, United States | — |
| Mercy Health Saint Mary's | Grand Rapids, Michigan, United States | — |
| Michigan Institute of Urology | Troy, Michigan, United States | — |
| Minnesota Urology | Plymouth, Minnesota, United States | — |
| Mayo Clinic Urology | Rochester, Minnesota, United States | — |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05226286